Coldstream Capital Management Inc Rocket Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,710 shares of RCKT stock, worth $13,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,710Holding current value
$13,423% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
263Shares Held
110MCall Options Held
567KPut Options Held
244K-
Rtw Investments, LP New York, NY17.7MShares$139 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$99.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$51.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$48.6 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$40.8 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $594M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...